Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
A number of medicine licence holders are carrying out precautionary medicine recalls at wholesale and pharmacy level. This follows evidence that the medicines, all manufactured at MJ Biopharm in India, did not meet European standards of Good Manufacturing Practice (GMP).
The MHRA has issued Class 2 drug alerts to healthcare professionals to support these precautionary recalls.
The recalls only relate to the medicines and the licence holders that are specified in the published drug alerts. The same medicines which are marketed by other companies are not affected by these alerts.
At present there is no specific evidence to suggest that the medicines are not safe for patient use.
Patients who have these medicines do not need to worry and should continue taking their medication. If patients have any concerns, they should speak to the pharmacist who dispensed the medicine.
